Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK Wunderman here has landed consumer-directed creative duties on AstraZeneca Pharmaceuticals’ Faslodex cancer drug after a review, the WPP Group shop confirmed.
AstraZeneca has not advertised Faslodex to consumers before so the assignment is new. Billings were not disclosed, but sources pegged them at $5-10 million.
Wunderman’s work will take the form of print ads and collateral pieces that will appear in doctors’ offices. The shop may also develop interactive ads. Its first campaign is expected this summer.
Faslodex
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in